EMRISE CORPORATION SELECTS RODMAN & RENSHAW LLC
AS FINANCIAL ADVISOR IN THE U.S.
Rodman to Assist with Strategic Business Plans Designed to Grow Company, Enhance Shareholder Value
DURHAM, NC - September 22, 2011 - EMRISE CORPORATION (OTCBB: EMRI), a multi-national manufacturer of defense, aerospace and industrial electronic devices and communications equipment, today announced it has selected Rodman & Renshaw, LLC (Rodman), a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), as its exclusive financial advisor in the United States. Rodman has been engaged to support the Company's growth strategy by assisting EMRISE in identifying and negotiating potential strategic merger, acquisition or alliance targets, by providing general financial advisory and support services as EMRISE executes its ongoing strategic business plans designed to grow the Company and enhance shareholder value.
EMRISE Chairman, President and Chief Executive Officer Carmine T. Oliva said that Rodman was selected from a number of leading investment banking firms who had expressed interest in working with the Company. "We believe Rodman is the right financial advisor for EMRISE, in part, due to the quality and experience of the investment banking team who will be working with us and also because of the breadth of services they offer," Oliva continued. "We are also impressed with the firm's recent growth and its track record of successfully completing financings and acquisition and sale transactions for small- and micro-cap companies."
About Rodman & Renshaw
Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.
Rodman & Renshaw, LLC, is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005.
For more information visit Rodman & Renshaw on the Internet at www.rodm.com
MEMBER FINRA, SIPC
About EMRISE Corporation
EMRISE designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. EMRISE products perform key functions such as power supply and power conversion; radio frequency (RF) and microwave signal processing; and network access and timing and synchronization of communications networks. The use of its network products in network timing and synchronization in edge networks is a primary growth driver for the Company's Communications Equipment business segment. The use of its power supplies, RF and microwave signal processing devices and subsystems in on-board in-flight entertainment and connectivity systems is a primary growth driver for the Company's Electronic Devices business segment. EMRISE serves the worldwide base of customers it has built in North America, Europe and Asia through operations in the United States, England and France. EMRISE is a publicly traded company whose common stock trades on the OTCBB under the symbol EMRI. For more information go to www.emrise.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
With the exception of historical information, certain matters discussed in this press release are forward looking statements within the meaning of the Private Securities Litigation Reform Act including but not limited to the Company's expectations that Rodman will assist in identifying and negotiating potential strategic merger, acquisition or alliance targets, and that EMRISE will execute its ongoing strategic business plans designed to enhance shareholder value. Such statements involve a number of risks and uncertainties, and the actual future results of EMRISE could differ from those statements. The Company refers you to those factors contained in the "Risk Factors" Section of EMRISE's Annual Report on Form 10-K for the year ended December 31, 2010, its Quarterly Reports on Form 10-Q, its Current Reports on Form 8-K filed in recent months, and other EMRISE filings with the SEC.
|
